Next Article in Journal
Bioremediation of Aflatoxin B1 by Meyerozyma guilliermondii AF01 in Peanut Meal via Solid-State Fermentation
Previous Article in Journal
Long-Term Adherence to Onabotulinum Toxin-A Intradetrusor Injections for Neurogenic Dysfunction in Children—A Retrospective Single-Center Evaluation
Previous Article in Special Issue
Mindfulness in Facilitating Pelvic Floor Botulinum Toxin Injection in Women with Chronic Pelvic Pain
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Enhancing Botulinum Toxin Injection Precision: The Efficacy of a Single Cadaveric Ultrasound Training Intervention for Improved Anatomical Localization

1
Division of Physical Medicine and Rehabilitation, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
2
Canadian Advances in Neuro-Orthopedics for Spasticity Congress (CANOSC), Kingston, ON K7K 1Z6, Canada
3
Faculty of Medicine, Paris Cité University, 75006 Paris, France
4
Department of Physical Medicine and Rehabilitation, GH St Louis Lariboisière F. Widal, 75010 Paris, France
5
Hotel Dieu Shaver Health and Rehabilitation Centre, St. Catharines, ON L2T 4C2, Canada
6
PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, France
7
Department of Physical Medicine and Rehabilitation, Poitiers University Hospital, 86000 Poitiers, France
*
Authors to whom correspondence should be addressed.
Toxins 2024, 16(7), 304; https://doi.org/10.3390/toxins16070304
Submission received: 24 April 2024 / Revised: 25 May 2024 / Accepted: 26 June 2024 / Published: 2 July 2024
(This article belongs to the Special Issue Uses of Botulinum Toxin Injection in Medicine)

Abstract

:
Ultrasound guidance can enhance existing landmark-based injection methods, even through a brief and single exposure during a cadaveric training course. A total of twelve participants were enrolled in this training program, comprising nine physical medicine and rehabilitation specialists, one pediatrician, and two physician assistants. For each participant, one upper-limb muscle and one lower-limb muscle were randomly chosen from the preselected muscle group. Subsequently, participants were tasked with injecting both of their chosen cadaveric muscles with 1 mL of acrylic paint using a manual needle palpation technique, relying solely on their knowledge of anatomic landmarks. Participants then underwent a personalized, one-to-one ultrasound teaching session, lasting approximately five minutes, conducted by two highly experienced instructors. Following this instructive phase, participants were tasked with a second round of injections, targeting the same two muscles in the lower and upper limbs. However, this time, the injections were performed using anatomical landmarks and ultrasound guidance. To facilitate differentiation from the initial injections, a distinct color of acrylic paint was employed. When employing the anatomical landmark-based approach, the overall success rate for injections was 67%, with 16 out of 24 targeted muscles accurately injected. With the incorporation of ultrasound guidance, the success rate was 92%, precisely targeting 22 out of the 24 muscles under examination. There was an improvement in injection accuracy achievable through the integration of ultrasound guidance, even with minimal training exposure. Our single cadaveric ultra-sound training program contributes valuable insights to the utilization of ultrasound for anatomy training to help optimize the targeting of BoNT-A.
Key Contribution: A substantial improvement in on-target injections with ultrasound anatomical landmarking was achieved after a brief training exposure. These results suggest that incorporating ultrasound into cadaveric spasticity courses can effectively improve the localization and targeting of key muscles in the limbs.

1. Introduction

Focal spasticity, characterized by muscle overactivity and increased tone, often presents a significant challenge in achieving precise and effective treatment following central nervous system injuries [1,2]. Among the various therapeutic approaches available, botulinum toxin type A (BoNT-A) injections have emerged as a first-line treatment for modulating specific muscle overactivity [3,4,5].
While BoNT-A injections have proven to be an invaluable tool in alleviating spasticity-related impairments, their efficacy is closely tied to optimal dose and precise targeting of affected muscles [6,7]. Indeed, achieving optimal treatment outcomes hinges upon the accurate identification and injection of the spastic muscle(s) [8,9,10,11].
Appropriate targeting of the spastic muscle(s) is of paramount importance, as the accuracy of injection location directly impacts treatment outcomes [12,13]. Traditional injection techniques based on anatomical landmarks have long served as the foundation of BoNT-A therapy. However, emerging evidence suggests that substantial enhancements in accuracy and efficacy can be achieved through the integration of ultrasound guidance [14,15,16,17,18,19,20]. The application of ultrasound in BoNT-A injections has garnered increasing attention, leading to a growing demand for ultrasound-guided BoNT-A injection courses [21,22,23].
As a result of problems with accuracy in using surface anatomy for muscles localization, there has been an increase in ultrasound education for targeting spastic muscles internationally and numerous courses have been developed to meet this need [12,17,24,25,26,27,28].
It has been shown that cadaveric-based anatomy learning is important to reinforce a clinician’s understanding of key muscles that are targeted for treatment with BoNT-A and can be complemented with ultrasound anatomy teaching [29,30,31,32].
In addition, incorporating the use of ultrasound to visualize muscle structures can help complement and improve anatomy knowledge and can in turn help improve procedural skills [33,34,35].
Our course included a component of a short ultrasound identification teaching (5 min) of muscles that were initially targeted using the traditional identification of muscles using surface-anatomy landmarks and from textbook landmarks that could help in improving the targeting of the muscles.
This paper, therefore, aims to show that integrating ultrasound guidance in a cadaveric spasticity course can significantly enhance existing landmark-based injection methods, even through a brief and single exposure during a cadaveric training course. By investigating the value of brief training in echo-guided BoNT-A injections, we hope to contribute valuable insights to the evolving landscape of BoNT-A therapy for focal spasticity management.
Within this context, our data collected were for quality assurance of our course but also to shed light on the comparison between traditional cadaveric-anatomy-based injection techniques and ultrasound-guided approaches for anatomical teaching, with a particular focus on commonly treated spastic muscles.

2. Results

All participants in the study successfully completed the comprehensive training course. The subsequent cadaveric dissections offered valuable insights into the precision of injection techniques.
When employing the anatomical landmark-based approach, the overall success rate for injections was determined to be 67%, with 16 out of 24 targeted muscles accurately injected. Within the upper limb, 8 out of 12 muscles were correctly targeted using the anatomical landmark technique. These successfully injected upper-limb muscles included triceps brachii, biceps brachii, brachialis, brachioradialis, pronator teres, flexor carpi radialis, flexor digitorum superficialis, and adductor pollicis. Notably, four upper-limb muscles—flexor carpi ulnaris, flexor digitorum profundus, flexor pollicis longus, and pronator quadratus—were missed when relying solely on anatomical landmarks. In the lower limb, the anatomical landmark technique achieved a success rate of 8 out of 12 muscles. These correctly injected lower-limb muscles included rectus femoris, vastus intermedius, iliopsoas, adductor magnus, gracilis, soleus, flexor hallucis longus, and tibialis posterior. Four lower-limb muscles, including adductor longus, medial gastrocnemius, lateral gastrocnemius, and flexor digitorum longus were missed when using the anatomic landmark technique.
With the incorporation of ultrasound guidance, there was an increase in the overall injection success rate, which surged to 92%, precisely targeting 22 out of the 24 muscles under examination. During this phase, only one upper-limb muscle, the adductor pollicis, and one lower-limb muscle, the adductor magnus, were not accurately injected (Table 1).
Significantly, when employing ultrasound guidance, the eight muscles that were initially missed with the anatomical landmark technique were accurately targeted. Conversely, the two muscles missed with ultrasound guidance were successfully injected using the anatomical landmark technique.
Statistical paired analyses, conducted to assess the impact of ultrasound guidance on injection accuracy, revealed a highly significant effect (p < 0.001). These findings underscore the substantial enhancement in precision and efficacy afforded by ultrasound guidance during BoNT-A injections for focal spasticity management in both the upper and lower limbs.

3. Discussion

Our findings reveal a notable improvement in injection accuracy when utilizing ultrasound guidance in addition to traditional manual palpation-based techniques. This higher success rate with ultrasound-guided injections underscores the substantial impact of incorporating ultrasound technology into the BoNT-A injection process when designing education curriculum and for the management of focal spasticity.
The clinical implications of these results are significant (Figure 1). Firstly, the incorporation of ultrasound for anatomical teaching is valuable to enhance the identification of key muscles for BoNT-A injections. Secondly, the enhanced accuracy achieved through ultrasound-guided injections can translate directly into improved patient outcomes. Accurately targeting the intended muscles is paramount in optimizing the therapeutic effects of BoNT-A, ultimately leading to improved spasticity management. Patients may experience reduced muscle hypertonia, decreased pain, improved motor function, and an enhanced quality of life. Furthermore, accurate muscle targeting can also reduce the rate of adverse effects, such as unwanted muscle weakness or pain from inadvertent injection of neighboring neurovascular structures.
Moreover, improved accuracy can potentially reduce the need for higher BoNT-A dosages, minimizing the risk of adverse effects and optimizing the utilization of this valuable therapeutic resource. Clinicians can also expect enhanced predictability in treatment outcomes, allowing for more tailored and effective treatment plans.
Our findings align with previous studies that have supported the use of ultrasound in guiding BoNT-A injections [36,37,38]. The literature consistently suggests that ultrasound guidance offers substantial advantages in terms of accuracy and precision. This includes studies highlighting the utility of ultrasound in various clinical contexts, such as musculoskeletal interventions [39,40,41,42].
There are many instances in which experienced clinicians rely on the anatomic descriptions found in textbooks for electromyographers to landmark the muscle to be injected when using guidance such as EMG for the BoNT-A injection technique [43,44]. Haig et al. revealed that the accuracy of blind needle placement in a cadaveric study using fine wire insertion according to muscle landmarks by Delagi and Perotto, Gierienger by seasoned Electromyographers was low. In this study, 36 different muscles in 10 cadaveric lower limbs were targeted with a fine wire using textbook landmarks of Delagi, Perotto, and Geiringer resulting in 263 targeted muscles. An anatomist blinded to the intended location dissected and recorded the muscles and other tissues that the wire pierced or passed nearby. The results showed that only 45% of the wire tip was in the intended muscle. Specific muscle accuracy was highly variable from 0% in 12 deep hip muscles to 100% in the vastus medialis [45].
An observational study by Henzel et al., using surface anatomy landmarks (based on Delagi and Perotto and anatomical published landmarks by Bickerton) to inject 18 patients with upper extremity flexor spasticity with BoNT-A and then using ultrasound for visualization of the muscle intended to be injected revealed significant variability regarding the accuracy of BoNT-A injection using surface anatomy and landmark-based palpation compared to ultrasound. The Henzel et al. study highlighted that surface anatomy localization by itself may not be very accurate, and that ultrasound can be used to enhance muscle targeting [43,46,47].
While our results reinforce these previous findings, it is essential to note that our study specifically examined the impact of a single brief exposure to ultrasound guidance to reinforce anatomy localization within a cadaveric model. This approach complements anatomy teaching and can help correct misguidances associated with anatomical landmarking techniques. The trainees reported improved procedural confidence after the brief ultrasound guidance teaching compared to their first injection attempt using only anatomical landmark based injection.
The success of anatomical landmarks in targeting the adductor pollicis and adductor magnus, despite the failing of ultrasound-guided injections, can be attributed to the unique challenges posed by small muscle targets and deep muscle targets using the out-of-plane technique in novice ultrasound injectors. The out-of-plane technique requires more practice for needle tip identification and tracking when injecting deeper seated muscles.
Despite our positive results, several limitations must be acknowledged. Firstly, the order of injections, whether based solely on anatomic landmarks or a combination of anatomical landmarks and ultrasound, was not randomized. This potential source of bias should be carefully considered when interpreting the results. The order of muscle injections was chosen from a proximal to distal orientation in order to avoid/limit disruption of freshly injected acrylic paint by subsequent injections by reducing repeat ultrasound probe pressure over injected muscles.
Furthermore, our study’s relatively small sample size, consisting of 12 participants, and the fact that each muscle was injected only twice by a single participant, warrant caution when generalizing our findings. Additionally, the cadaveric model, while valuable for controlled experiments, may not fully replicate the clinical environment.
Another notable limitation of our study is the retrospective data collection method employed. This retrospective approach prevented us from determining which specific trainees faced challenges in injection accuracy and subsequently analyzing potential contributing factors such as their level of experience or specialty. While this limitation restricts our ability to offer deeper insights into the individual performance of trainees, it is important to highlight that despite the majority of trainees having little to no prior experience in ultrasound-guided injections, the overall success rate in ultrasound-guided injections remained notably high. This finding emphasizes the feasibility and potential for rapid proficiency in ultrasound-guided injection techniques, highlighting the promise of integrating this technology into the clinical practice of various healthcare professionals, even those who are relatively new to the methodology.
Further research with larger cohorts and clinical studies involving live patients will be instrumental in corroborating and expanding upon our observations.
It is important to note that our course utilizing the short brief ultrasound exposure does not imply that the clinicians become experts in utilizing the ultrasound on a single exposure. It takes a significant amount of training, volume of patients seen, and attending more formalized courses to become proficient in the use of ultrasound for targeting botulinum toxin into spastic muscles. Our course demonstrates that a single ultrasound exposure can help reinforce anatomy teaching and can be incorporated into existing cadaveric-based anatomy teaching to help optimize the clinician’s confidence in visualizing the muscle to be injected.

4. Conclusions

The use of ultrasound in cadaveric-based BoNT-A intervention training demonstrates the substantial improvement in injection accuracy achievable through the integration of ultrasound guidance, even with minimal training exposure.
The combination of ultrasound within a cadaveric course should be considered when developing an educational curriculum at the residency and for clinicians attending cadaveric-based spasticity injection courses.
The ability to visualize muscle and neurovascular structures in real time can help the clinician better understand the “whole picture” rather than just looking at the target. The ultrasound image can allow the clinician to look beyond the target (i.e., looking beyond the muscle to be injected and also assessing other adjacent muscles and neurovascular and bony structures) and this may allow better visualization and a better appreciation of a patient’s anatomy. The techniques employed by this study, including a brief exposure to focused, high-level ultrasound training to repeat a muscle target injection with acrylic paint followed by cadaveric dissection of the injected limbs allowed the trainees to analyze and compare the advantages and disadvantages of anatomical landmarking versus ultrasound-guided injections. While the study has its limitations, it contributes valuable insights to the evolving landscape of BoNT-A therapy for focal spasticity management, setting the stage for the enhancement of curriculum design and for future investigations and advancements in this field.

5. Materials and Methods

5.1. Study Participants and Settings

A comprehensive two-day training course was held at a university cadaveric lab offering formal anatomy teaching, didactic instruction, and hands-on ultrasound scanning using cadaveric specimens. There were 2 physicians instructors experienced in ultrasonography and one anatomist for cadaver dissection.
Pre-COVID, this was a yearly course conducted since 2016, and primary data for program evaluation from the last course in 2019 was collected as part of the course design and then used as secondary data for quality assurance of the cadaveric teaching and ultrasound course.
This course was tailored explicitly to early-career clinicians who had already completed their post-graduate training and had some experience in botulinum toxin type A (BoNT-A) injections, with less than five years of clinical practice. A total of twelve participants were enrolled in this training program, comprising nine physical medicine and rehabilitation (PMR) specialists, one pediatrician, and two physician assistants, all in the first five years of their professional practice.
Whole-body cadaveric specimen tissue was prepared using Surgical Reality Fluid (Trinity Fluids, LLC., Harsens Island, MI, USA) to facilitate tissue storage and longevity while preserving the natural characteristics required to achieve limb pliability and maintain soft tissue sonographic characteristics [48].
Acrylic paints by ARTIST’S LOFT™ (Michaels store, Oakville, ON, Canada https://canada.michaels.com (accessed on 1 December 2023)) were utilized for intra-muscular injection in the cadaveric specimen. After testing several variations of India ink with thickening agents such as cornstarch and injectable hardening agents, it was established by one of the authors (O.K.) that acrylic paint maintained the most ideal characteristics for ease of injection, essentially unlimited injection time after syringe preparation and good injection localization within cadaveric tissue. It was also very cost-effective and consistent between all injectate colors.
The ultrasound machines used were Esaote MyLab 7 equipped with a 13–3 Hz linear array transducer, (Esaote; location: Fishers, IN, USA) and a 13–3 Hz linear array transducer, (Esaote; location: Fishers, IN, USA), with MSK (B-mode) and a setting and depth of 4 cm for the upper limb and 5 cm for the lower limb. Focal zone and gain settings were established by the training instructors for image optimization.

5.2. Study Design

5.2.1. Anatomic Landmark Injections

The muscles commonly targeted for BoNT-A injection were preselected by two experienced training instructors. For the upper limb, the study focused on the following 12 muscles: triceps brachii, biceps brachii, brachialis, brachioradialis, pronator teres, flexor carpi radialis, flexor carpi ulnaris, flexor digitorum superficialis, flexor digitorum profundus, flexor pollicis longus, pronator quadratus and adductor pollicis. In the lower limb, the selected muscles included adductor longus, adductor magnus, rectus femoris, vastus intermedius, iliopsoas, gracilis, soleus, medial gastrocnemius, lateral gastrocnemius, flexor digitorum longus, flexor hallucis longus, and tibialis posterior.
For each participant, one upper-limb muscle and one lower-limb muscle were randomly chosen from the preselected muscle group. Subsequently, participants were tasked with injecting both of their chosen cadaveric muscles with 1 mL of acrylic paint and 2-inch 21G needles using a manual needle palpation technique, relying solely on their knowledge of anatomic landmarks. The ultrasound-guided injection technique used was out of plane for all the muscles.

5.2.2. Ultra-Sound Individualized Training

Subsequently, each participant underwent a personalized, one-to-one ultrasound teaching session, lasting approximately five minutes, conducted by two highly experienced instructors. During this session, the instructors guided the participants in utilizing ultrasound in addition to their knowledge of anatomical landmarks to precisely identify the previously targeted muscles in both the lower and upper limbs.

5.2.3. Ultra-Sound Guided Injections

Following this instructive phase, participants were tasked with a second round of injections using in-plane ultrasound-guided injections, targeting the same two muscles in the lower and upper limbs. However, this time, the injections were performed using anatomical landmarks and ultrasound guidance. To facilitate differentiation from the initial injections, a distinct color of acrylic paint was employed. The interval between the ultrasound individualized training and the ultrasound-guided injections was set at 30 min, allowing participants to apply the newly acquired ultrasound skills promptly.

5.2.4. Analysis of the Injection’s Accuracy

To rigorously assess the precision and accuracy of the injection techniques employed, an experienced anatomist with expertise in musculoskeletal anatomy conducted meticulous cadaveric dissections. These dissections were carried out blindly, without prior knowledge of the specific injection techniques used but also blinded with regards to the meaning of ink color (i.e., the color-coding of “first” vs. “second” injection) and the intended target muscle. These dissections were undertaken with the specific objective of discerning the exact locations of acrylic paint placement resulting from the anatomic landmark-based injection approach and from the ultrasound-guided injection technique.

5.3. Statistical Analysis

All statistical analyses were performed using the Jamovi software tool (version 2.3.28). We conducted paired statistical analysis, specifically McNemar’s Test, to compare participant performance before and after individualized ultrasound training. The significance level was set at p = 0.05 to determine the statistical significance of any observed changes.

5.4. Ethics

Participation in the cadaveric teaching program was based on the university’s anatomical lab agreement to consent to the anatomy lab’s ethical standards. The authors state that every effort was made to follow all local and international ethical guidelines and laws that pertain to the use of human cadaveric donors in anatomical research.
Quality assurance and quality improvement (QA/QI) studies, program evaluation activities, performance reviews, or testing within normal educational requirements when used exclusively for assessment, management, or improvement purposes, do not constitute research under the TCPS 2 (2018) and do not fall under the scope of REB of the University of British Columbia review (https://ethics.gc.ca/eng/tcps2-eptc2_2018_chapter2-chapitre2.html#5, accessed on 1 December 2023).

Author Contributions

Conceptualization, methodology: R.R. and O.K.; formal analysis: C.H. (Camille Heslot); writing—original draft preparation: C.H. (Camille Heslot); writing—review and editing: R.R., R.D., A.S., C.H. (Camille Heslot) and C.H. (Chloe Haldane); supervision: R.R. and O.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki. The authors state that every effort was made to follow all local and international ethical guidelines and laws that pertain to the use of human cadaveric donors in anatomical research.

Informed Consent Statement

The anatomy lab orientation form was completed and signed by all subjects involved in the study.

Data Availability Statement

Data are not publicly available but can be sent by authors on reasonable requests.

Acknowledgments

The authors thank all participants who participated in this study for their valuable time and participation.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Dressler, D.; Bhidayasiri, R.; Bohlega, S.; Chana, P.; Chien, H.F.; Chung, T.M.; Colosimo, C.; Ebke, M.; Fedoroff, K.; Frank, B.; et al. Defining spasticity: A new approach considering current movement disorders terminology and botulinum toxin therapy. J. Neurol. 2018, 265, 856–862. [Google Scholar] [CrossRef] [PubMed]
  2. Pandyan, A.; Gregoric, M.; Barnes, M.; Wood, D.; Wijck, F.V.; Burridge, J.; Hermens, H.; Johnson, G. Spasticity: Clinical perceptions, neurological realities and meaningful measurement. Disabil. Rehabil. 2005, 27, 2–6. [Google Scholar] [CrossRef] [PubMed]
  3. Moeini-Naghani, I.; Hashemi-Zonouz, T.; Jabbari, B. Botulinum Toxin Treatment of Spasticity in Adults and Children. Semin. Neurol. 2016, 36, 64–72. [Google Scholar] [CrossRef] [PubMed]
  4. Simpson, D.M.; Hallett, M.; Ashman, E.J.; Comella, C.L.; Green, M.W.; Gronseth, G.S.; Armstrong, M.J.; Gloss, D.; Potrebic, S.; Jankovic, J.; et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016, 86, 1818–1826. [Google Scholar] [CrossRef] [PubMed]
  5. Chen, Y.-T.; Zhang, C.; Liu, Y.; Magat, E.; Verduzco-Gutierrez, M.; Francisco, G.E.; Zhou, P.; Zhang, Y.; Li, S. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia. Toxins 2020, 12, 492. [Google Scholar] [CrossRef] [PubMed]
  6. Francisco, G.; Balbert, A.; Bavikatte, G.; Bensmail, D.; Carda, S.; Deltombe, T.; Draulans, N.; Escaldi, S.; Gross, R.; Jacinto, J.; et al. A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus. J. Rehabil. Med. 2021, 53, jrm00134. [Google Scholar] [CrossRef] [PubMed]
  7. Schnitzler, A.; Dince, C.; Freitag, A.; Iheanacho, I.; Fahrbach, K.; Lavoie, L.; Loze, J.-Y.; Forestier, A.; Gasq, D. AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review. Toxins 2022, 14, 734. [Google Scholar] [CrossRef]
  8. Wissel, J.; Ward, A.; Erztgaard, P.; Bensmail, D.; Hecht, M.; Lejeune, T.; Schnider, P. European consensus table on the use of botulinum toxin type A in adult spasticity. J. Rehabil. Med. 2009, 41, 13–25. [Google Scholar] [CrossRef]
  9. Chan, A.K.; Finlayson, H.; Mills, P.B. Does the method of botulinum neurotoxin injection for limb spasticity affect outcomes? A systematic review. Clin. Rehabil. 2017, 31, 713–721. [Google Scholar] [CrossRef]
  10. Py, A.-G.; Zein Addeen, G.; Perrier, Y.; Carlier, R.-Y.; Picard, A. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance. Ann. Phys. Rehabil. Med. 2009, 52, 215–223. [Google Scholar] [CrossRef]
  11. Picelli, A.; Tamburin, S.; Bonetti, P.; Fontana, C.; Barausse, M.; Dambruoso, F.; Gajofatto, F.; Santilli, V.; Smania, N. Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Spastic Equinus in Adults With Stroke: A Randomized Controlled Trial Comparing Manual Needle Placement, Electrical Stimulation and Ultrasonography-Guided Injection Techniques. Am. J. Phys. Med. Rehabil. 2012, 91, 957–964. [Google Scholar] [CrossRef] [PubMed]
  12. Lagnau, P.; Lo, A.; Sandarage, R.; Alter, K.; Picelli, A.; Wissel, J.; Verduzco-Gutierrez, M.; Suputtitada, A.; Munin, M.C.; Carda, S.; et al. Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion. Toxins 2021, 13, 249. [Google Scholar] [CrossRef] [PubMed]
  13. Suputtitada, A.; Chatromyen, S.; Chen, C.P.C.; Simpson, D.M. Best Practice Guidelines for the Management of Patients with Post-Stroke Spasticity: A Modified Scoping Review. Toxins 2024, 16, 98. [Google Scholar] [CrossRef] [PubMed]
  14. Alter, K.; Karp, B. Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures. Toxins 2017, 10, 18. [Google Scholar] [CrossRef] [PubMed]
  15. Moreta, M.C.; Fleet, A.; Reebye, R.; McKernan, G.; Berger, M.; Farag, J.; Munin, M.C. Reliability and Validity of the Modified Heckmatt Scale in Evaluating Muscle Changes With Ultrasound in Spasticity. Arch. Rehabil. Res. Clin. Transl. 2020, 2, 100071. [Google Scholar] [CrossRef] [PubMed]
  16. Elovic, E.P.; Esquenazi, A.; Alter, K.E.; Lin, J.L.; Alfaro, A.; Kaelin, D.L. Chemodenervation and Nerve Blocks in the Diagnosis and Management of Spasticity and Muscle Overactivity. PM&R 2009, 1, 842–851. [Google Scholar] [CrossRef]
  17. Kaymak, B.; Malas, F.; Kara, M.; On, A.; Özçakar, L. Comment on Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures. Toxins 2017, 10, 18—Quintessential Use of Ultrasound Guidance for Botulinum Toxin Injections—Muscle Innervation Zone Targeting Revisited. Toxins 2018, 10, 396. [Google Scholar] [CrossRef]
  18. Santamato, A.; Micello, M.F.; Panza, F.; Fortunato, F.; Baricich, A.; Cisari, C.; Pilotto, A.; Logroscino, G.; Fiore, P.; Ranieri, M. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. J. Neurol. Sci. 2014, 347, 39–43. [Google Scholar] [CrossRef]
  19. Picelli, A.; Baricich, A.; Chemello, E.; Smania, N.; Cisari, C.; Gandolfi, M.; Cinone, N.; Ranieri, M.; Santamato, A. Ultrasonographic Evaluation of Botulinum Toxin Injection Site for the Medial Approach to Tibialis Posterior Muscle in Chronic Stroke Patients with Spastic Equinovarus Foot: An Observational Study. Toxins 2017, 9, 375. [Google Scholar] [CrossRef]
  20. Schnitzler, A.; Roche, N.; Denormandie, P.; Lautridou, C.; Parratte, B.; Genet, F. Manual needle placement: Accuracy of botulinum toxin a injections. Muscle Nerve 2012, 46, 531–534. [Google Scholar] [CrossRef]
  21. Luz, J.; Siddiqui, I.; Jain, N.B.; Kohler, M.J.; Donovan, J.; Gerrard, P.; Borg-Stein, J. Resident-Perceived Benefit of a Diagnostic and Interventional Musculoskeletal Ultrasound Curriculum: A Multifaceted Approach Using Independent Study, Peer Teaching, and Interdisciplinary Collaboration. Am. J. Phys. Med. Rehabil. 2015, 94, 1095–1103. [Google Scholar] [CrossRef]
  22. Sanders, J.; Noble, V.; Raja, A.; Sullivan, A.; Camargo, C. Access to and Use of Point-of-Care Ultrasound in the Emergency Department. West. J. Emerg. Med. 2015, 16, 747–752. [Google Scholar] [CrossRef] [PubMed]
  23. Wong, J.; Montague, S.; Wallace, P.; Negishi, K.; Liteplo, A.; Ringrose, J.; Dversdal, R.; Buchanan, B.; Desy, J.; Ma, I.W.Y. Barriers to learning and using point-of-care ultrasound: A survey of practicing internists in six North American institutions. Ultrasound J. 2020, 12, 19. [Google Scholar] [CrossRef] [PubMed]
  24. Toxin Academy. Toxin Academy Courses. Available online: http://toxinacademy.com/courses.html (accessed on 1 December 2023).
  25. American Academy of Physical Medicine and Rehabilitation. AAPMR Annual Assembly Ultrasound-Guided Chemodenervation Skills Labs. Available online: https://www.aapmr.org/education/annual-assembly (accessed on 1 December 2023).
  26. American Academy of Physical Medicine and Rehabilitation. STEP Interventional Spasticity Certificate Program. Available online: https://www.aapmr.org/education/step-certificate-programs/step-interventional-spasticity-certificate-program (accessed on 1 December 2023).
  27. Shroeder, A.S.; Berweck, S.; Fietzek, U.M.; Doberauer, J.; Wurzinger, L.; Reiter, K.; Wissel, J.; Heinen, F. Munich Ultrasound Course. Available online: http://munichultrasoundcourse.com/ (accessed on 1 December 2023).
  28. Buyukavci, R.; Akturk, S.; Ersoy, Y. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: An observational study. Eur. J. Phys. Rehabil. Med. 2018, 54, 738–744. [Google Scholar] [CrossRef]
  29. Bushi, S.; Kirshblum, S.; Ezepue, T.; Ma, R. Perceived Benefits of a Cadaver-Based Ultrasound Procedure Workshop for Physical Medicine and Rehabilitation Trainees. Am. J. Phys. Med. Rehabil. 2022, 101, e18–e21. [Google Scholar] [CrossRef]
  30. Alter, K.E. Ultrasound-Guided Chemodenervation Procedures: Text and Atlas; Demos Medical: New York, NY, USA, 2012. [Google Scholar]
  31. Krähenbühl, S.M.; Čvančara, P.; Stieglitz, T.; Bonvin, R.; Michetti, M.; Flahaut, M.; Durand, S.; Deghayli, L.; Applegate, L.A.; Raffoul, W. Return of the cadaver: Key role of anatomic dissection for plastic surgery resident training. Medicine 2017, 96, e7528. [Google Scholar] [CrossRef] [PubMed]
  32. Kovacs, G.; Levitan, R.; Sandeski, R. Clinical Cadavers as a Simulation Resource for Procedural Learning. AEM Educ. Train. 2018, 2, 239–247. [Google Scholar] [CrossRef]
  33. Allsop, S.; Gandhi, S.; Ridley, N.; Spear, M. Implementing ultrasound sessions to highlight living anatomy for large medical student cohorts. Transl. Res. Anat. 2021, 22, 100088. [Google Scholar] [CrossRef]
  34. Sites, B.; Spence, B.; Gallagher, J.; Wiley, C.; Bertrand, M.; Blike, G. Characterizing Novice Behavior Associated with Learning Ultrasound-Guided Peripheral Regional Anesthesia. Reg. Anesth. Pain Med. 2007, 32, 107–115. [Google Scholar] [CrossRef]
  35. Chapman, G.A.; Johnson, D.; Bodenham, A.R. Visualisation of needle position using ultrasonography. Anaesthesia 2006, 61, 148–158. [Google Scholar] [CrossRef]
  36. Ko, Y.D.; Yun, S.I.; Ryoo, D.; Chung, M.E.; Park, J. Accuracy of Ultrasound-Guided and Non-guided Botulinum Toxin Injection into Neck Muscles Involved in Cervical Dystonia: A Cadaveric Study. Ann. Rehabil. Med. 2020, 44, 370–377. [Google Scholar] [CrossRef]
  37. Koo, H.J.; Park, H.J.; Park, G.-Y.; Han, Y.; Sohn, D.; Im, S. Safe Needle Insertion Locations for Motor Point Injection of the Triceps Brachii Muscle: A Pilot Cadaveric and Ultrasonography Study. Ann. Rehabil. Med. 2019, 43, 635–641. [Google Scholar] [CrossRef]
  38. Finnoff, J.T.; Hurdle, M.F.B.; Smith, J. Accuracy of Ultrasound-Guided Versus Fluoroscopically Guided Contrast-Controlled Piriformis Injections: A Cadaveric Study. J. Ultrasound Med. 2008, 27, 1157–1163. [Google Scholar] [CrossRef]
  39. Smith, J.; Wisniewski, S.J.; Wempe, M.K.; Landry, B.W.; Sellon, J.L. Sonographically Guided Obturator Internus Injections: Techniques and Validation. J. Ultrasound Med. 2012, 31, 1597–1608. [Google Scholar] [CrossRef]
  40. Rha, D.; Lee, S.-H.; Lee, H.-J.; Choi, Y.-J.; Kim, H.-J.; Lee, S.C. Ultrasound-Guided Injection of the Adductor Longus and Pectineus in a Cadaver Model. Pain Physician 2015, 18, E1111–E1117. [Google Scholar]
  41. Lee, S.C.; Rha, D.; Kim, H.-J.; Yang, H.; Lee, S.-H.; Koh, D. Ultrasound-Guided Injection of the Intrapelvic Portion of the Obturator Internus in a Cadaver Model. Reg. Anesth. Pain Med. 2014, 39, 347–350. [Google Scholar] [CrossRef]
  42. Dauffenbach, J.; Pingree, M.J.; Wisniewski, S.J.; Murthy, N.; Smith, J. Distribution Pattern of Sonographically Guided Iliopsoas Injections: Cadaveric Investigation Using Coned Beam Computed Tomography. J. Ultrasound Med. 2014, 33, 405–414. [Google Scholar] [CrossRef]
  43. Delagi, E.F.; Perotto, A.O.; Hammond, P.B. (Eds.) Anatomical Guide for the Electromyographer: The Limbs and Trunk, 5th ed.; Charles C. Thomas: Springfield, IL, USA, 2011. [Google Scholar]
  44. Geiringer, S.R.; Davidson, S. Anatomic Localization for Needle Electromyography, 2nd ed.; Hanley & Belfus: Philadelphia, PA, USA, 1999. [Google Scholar]
  45. Haig, A.J.; Goodmurphy, C.W.; Harris, A.R.; Ruiz, A.P.; Etemad, J. The accuracy of needle placement in lower-limb muscles: A blinded study11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated. Arch. Phys. Med. Rehabil. 2003, 84, 877–882. [Google Scholar] [CrossRef] [PubMed]
  46. Henzel, M.K.; Munin, M.C.; Niyonkuru, C.; Skidmore, E.R.; Weber, D.J.; Zafonte, R.D. Comparison of Surface and Ultrasound Localization to Identify Forearm Flexor Muscles for Botulinum Toxin Injections. PM&R 2010, 2, 642–646. [Google Scholar] [CrossRef]
  47. Bickerton, L.E.; Agur, A.M.R.; Ashby, P. Flexor digitorum superficialis: Locations of individual muscle bellies for botulinum toxin injections. Muscle Nerve 1997, 20, 1041–1043. [Google Scholar] [CrossRef]
  48. Wang, A.; De Sa, D.; Darie, S.; Zhang, B.; Rockarts, J.; Palombella, A.; Nguyen, L.; Downer, N.; Wainman, B.; Monteiro, S. Development of the McMaster Embalming Scale (MES) to assess embalming solutions for surgical skills training. Clin. Anat. 2023, 36, 754–763. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Key points of this study.
Figure 1. Key points of this study.
Toxins 16 00304 g001
Table 1. Results of the injection accuracy in the targeted muscles. HIT: properly targeted injection, MISS: Unproperly targeted injection.
Table 1. Results of the injection accuracy in the targeted muscles. HIT: properly targeted injection, MISS: Unproperly targeted injection.
Target MuscleAnatomical GuidanceUltrasound Guidance
Upper limb
  triceps brachiiHITHIT
  biceps brachiiHITHIT
  brachialisHITHIT
  brachioradialisHITHIT
  pronator teresHITHIT
  flexor carpi radialisHITHIT
  flexor carpi ulnarisMISSHIT
  flexor digitorum superficialisHITHIT
  flexor digitorum profundusMISSHIT
  flexor pollicis longusMISSHIT
  pronator quadratusMISSHIT
  adductor pollicisHITMISS
Lower Limb
  adductor longusMISSHIT
  adductor magnusHITMISS
  rectus femorisHITHIT
  vastus intermediusHITHIT
  iliopsoasHITHIT
  gracilisHITHIT
  soleusHITHIT
  medial gastrocnemiusMISSHIT
  lateral gastrocnemiusMISSHIT
  flexor digitorum longusMISSHIT
  flexor hallucis longusHITHIT
  tibialis posteriorHITHIT
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Heslot, C.; Khan, O.; Schnitzler, A.; Haldane, C.; David, R.; Reebye, R. Enhancing Botulinum Toxin Injection Precision: The Efficacy of a Single Cadaveric Ultrasound Training Intervention for Improved Anatomical Localization. Toxins 2024, 16, 304. https://doi.org/10.3390/toxins16070304

AMA Style

Heslot C, Khan O, Schnitzler A, Haldane C, David R, Reebye R. Enhancing Botulinum Toxin Injection Precision: The Efficacy of a Single Cadaveric Ultrasound Training Intervention for Improved Anatomical Localization. Toxins. 2024; 16(7):304. https://doi.org/10.3390/toxins16070304

Chicago/Turabian Style

Heslot, Camille, Omar Khan, Alexis Schnitzler, Chloe Haldane, Romain David, and Rajiv Reebye. 2024. "Enhancing Botulinum Toxin Injection Precision: The Efficacy of a Single Cadaveric Ultrasound Training Intervention for Improved Anatomical Localization" Toxins 16, no. 7: 304. https://doi.org/10.3390/toxins16070304

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop